Tumor necrosis factor alpha induces stronger cytotoxicity in ABCG2-overexpressing resistant breast cancer cells compared with their drug-sensitive parental line

DNA and Cell Biology

Volumn 30, Issue 6, 2011, Pages 413-418

  Mosaffa, Fatemeh ^a   Kalalinia, Fatemeh ^a   Parhiz, Bibi Hamideh ^a   Behravan, Javad ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BREAST CANCER RESISTANCE PROTEIN; MITOXANTRONE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER RESISTANCE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MITOXANTRONE; NEOPLASM PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79958239181     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2010.1143     Document Type: Article

References (21)

1. Agostinelli, E., and Seiler, N. (2007). Lysosomotropic compounds and spermine enzymatic oxidation products in cancer therapy (review). Int J Oncol 31, 473-484.
2. Borsellino, N., Crescimanno, M., Flandina, C., Flugy, A., and D'Alessandro, N. (1994). Combined activity of interleukin-1 alpha or TNF-alpha and doxorubicin on multidrug resistant cell lines: evidence that TNF and DXR have synergistic anti-tumor and differentiation-inducing effects. Anticancer Res 14, 2643-2648.
3. Calcabrini, A., Arancia, G., Marra, M., Crateri, P., Befani, O., Martone, A., and Agostinelli, E. (2002). Enzymatic oxidation products of spermine induce greater cytotoxic effects on human multidrug-resistant colon carcinoma cells (LoVo) than on their wild-type counterparts. Int J Cancer 99, 43-52. (Pubitemid 34273196)
4. Cenni, V., Maraldi, N.M., Ruggeri, A., Secchiero, P., Del Coco, R., De Pol, A., Cocco, L., and Marmiroli, S. (2004). Sensitiza-tion of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/ PKB kinase. Int J Oncol 25, 1599-1608.
5. D'Alessandro, N., Flugy, A., Tolomeo, M., and Dusonchet, L. (1998). The apoptotic signaling of TNF-alpha in multidrug resistant Friend leukemia cells. Anticancer Res 18, 3065-3072. (Pubitemid 28388817)
6. Flugy, A., Borsellino, N., and D'Alessandro, N. (1995). TNF-induced apoptosis in multidrug resistant friend ery-throleukemia is not influenced by the P-glycoprotein and glutathione status of the cell line. Oncol Res 7, 559-564. (Pubitemid 26075388)
7. Jin, J., Shahi, S., Kang, H.K., Van Veen, H.W., Fan, T.P. (2006). Metabolites of ginsenosides as novel BCRP inhibitors. Bio-chem Biophys Res Commun 345, 1308-1314. (Pubitemid 43817877)
8. Kim, H.S., Lee, T.B., and Choi, C.H. (2001). Down-regulation of catalase gene expression in the doxorubicin-resistant AML subline AML-2/DX100. Biochem Biophys Res Commun 281, 109-114.
9. Liu, F., Fan, D., Qi, J., Zhu, H., Zhou, Y., Yang, C., Zhu, Z., and Xiong, D. (2008). Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line. Life Sci 83, 496-501.
10. Lupertz, R., Chovolou, Y., Kampkotter, A., Watjen, W., and Kahl, R. (2008). Catalase overexpression impairs TNF-alpha induced NF-kappaB activation and sensitizes MCF-7 cells against TNF-alpha. J Cell Biochem 103, 1497-1511. (Pubitemid 351490718)
11. Mao, Q., and Unadkat, J.D. (2005). Role of the breast cancer resistance protein (ABCG2) in drug transport. AAPS J 7, E118-E133. (Pubitemid 41554295)
12. Mosaffa, F., Lage, H., Afshari, J.T., and Behravan, J. (2009). Interleukin-1 beta and tumor necrosis factor-alpha increase ABCG2 expression in MCF-7 breast carcinoma cell line and its mitoxantrone-resistant derivative, MCF-7/MX. Inflamm Res 58, 669-676.
13. Murley, J.S., Kataoka, Y., Hallahan, D.E., Roberts, J.C., and Grdina, D.J. (2001). Activation of NFkappaB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells. Free Radic Biol Med 30, 1426-1439. (Pubitemid 32522958)
14. Robey, R.W., Honjo, Y., van de Laar, A., Miyake, K., Regis, J.T., Litman, T., and Bates, S.E. (2001). A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2). Biochim Biophys Acta 1512, 171-182. (Pubitemid 32530764)
15. Ross, D.D., Yang, W., Abruzzo, L.V., Dalton, W.S., Schneider, E., Lage, H., Dietel, M., Greenberger, L., Cole, S.P., and Doyle, L.A. (1999). Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J Natl Cancer Inst 91, 429-433. (Pubitemid 29128278)
16. Salmon, S.E., Soehnlen, B., Dalton, W.S., Meltzer, P., and Scu-deri, P. (1989). Effects of tumor necrosis factor on sensitive and multidrug resistant human leukemia and myeloma cell lines. Blood 74, 1723-1727. (Pubitemid 19251552)
17. Stein, U., and Walther, W. (1998). Cytokine-mediated reversal of multidrug resistance. Cytotechnology 27, 271-282. (Pubitemid 29025475)
18. Van der Heijden, J., de Jong, M.C., Dijkmans, B.A., Lems, W.F., Oerlemans, R., Kathmann, I., Schalkwijk, C.G., Scheffer, G.L., Scheper, R.J., and Jansen, G. (2004). Development of sulfasa-lazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFalpha. Ann Rheum Dis 63, 138-143. (Pubitemid 38122131)
19. Wang, Y.R., Wen, S.P., Wang, F.X., Wen, L., Yang, B.Y., Yang, J.C., Zhang, X.J., and Yang, S.F. (2008). [Apoptosis of the adriamycin-resistant leukemia cell line induced by the re-combinant mutant human TNF-related apoptosis-inducing li-gand combined with arsenic trioxide]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16, 1055-1059.
20. Wang, Z., Kishimoto, H., Bhat-Nakshatri, P., Crean, C., and Nakshatri, H. (2005). TNFalpha resistance in MCF-7 breast cancer cells is associated with altered subcellular localization of p21CIP1 and p27KIP1. Cell Death Differ 12, 98-100. (Pubitemid 40090034)
21. Yin, Y., Allen, P.D., Jia, L., MacEy, M.G., Kelsey, S.M., Newland, A.C. (2006). Constitutive levels of cAMP-dependent protein kinase activity determine sensitivity of human multidrug-resistant leukaemic cell lines to growth inhibition and apop-tosis by forskolin and tumour necrosis factor alpha. Br. J. haematol 08, 565-573.